One cancer drug turned down after many years of research, but the company plans an appeal. The FDA continues to ask for substantial documentation in the hopes of better decision. Refusals don't help the cause when it comes to investors and the potential for continued research. Something...
This is an interesting opinion story from an individual that has a natural health site, which many have been criticized over the years as over talking what natural herbs and cures can product as far as results. This particular individual states only 1% of his entire site was related to cancer and...
Additional information is available at the website along with a listing of the peer committee. Over $350 million has been raised by the foundation. In addition to the Young Investigators awards the Challenge Awards were also recently in the news and announced. Online donations and subscriptions...
Posted to
The Medical Quack .... by Barbara Duck
on 08-19-2008
Filed under: Medically Related, Pharma/FDA News, cancer research, Research, Oncology, Prostate Cancer, PCF, Pathology, Prostate Cancer Foundation, Radiation Oncology, Healthcare Awards, Imaging Science, Molecular Science
Patrice Milos, Vice President and Chief Scientific Officer, Helicos Biosciences This week I had the opportunity to talk with Patrice Milos from Helicos Biosciences who has a long background in global research and spent a number of years at Pfizer as Executive Director at Pfizer Global Research and Development...
Posted to
The Medical Quack .... by Barbara Duck
on 08-15-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, personalized medicine, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, DNA Testing, Phamaceuticals, Helios
The software offers both detailed, localized views of genomic data, and a whole genome view, in a format somewhat similar to the way Google presents items on the web. It is free to download and use. There are also some sample data files available. I like the idea of the heat map view...
Posted to
The Medical Quack .... by Barbara Duck
on 08-06-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, DNA, Genomics, Research, Pharmacogenomics, MIT, Biomed, Broad Institute, Harvard
The program uses just plain old Java, but add this technology with sequencing information and with the 4D applications, studies can be virtually conducted to see how a medication would react with selected settings. Its resolution is scaleable to 100,000,000 pixels and more by using more than one...
Posted to
The Medical Quack .... by Barbara Duck
on 08-05-2008
Filed under: Medically Related, Technology, Pharma/FDA News, DNA, Genomics, Research, Pharmacogenomics, Biomed, Disease, Virtual Reality
This is one tough subject by all means. Yes, consumers want early access, but on the other hand if there’s not enough information regarding issues such as side effects, a drug could in fact hasten the process with individuals dying sooner, again studies are what is needed to be safe. ...
Posted to
The Medical Quack .... by Barbara Duck
on 07-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Cancer, FDA, clinical trials, Research, University of California